Jim Simons Cognition Therapeutics Inc Transaction History
Renaissance Technologies LLC
- $63.4 Billion
- Q4 2024
A detailed history of Jim Simons (Renaissance Technologies LLC) transactions in Cognition Therapeutics Inc stock. As of the latest transaction made, Renaissance Technologies LLC holds 91,100 shares of CGTX stock, worth $38,262. This represents 0.0% of its overall portfolio holdings.
Number of Shares
91,100
Previous 88,700
2.71%
Holding current value
$38,262
Previous $41,000
65.85%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding CGTX
# of Institutions
50Shares Held
13.4MCall Options Held
0Put Options Held
0-
Bios Capital Management, LP Fort Worth, TX6MShares$2.52 Million4.39% of portfolio
-
Pathstone Family Office, LLC Englewood, NJ2.21MShares$926,2580.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.24MShares$520,6180.0% of portfolio
-
Sigma Planning Corp Ann Arbor, MI614KShares$258,0850.01% of portfolio
-
Alyeska Investment Group, L.P. Chicago, IL500KShares$210,0000.0% of portfolio
About COGNITION THERAPEUTICS INC
- Ticker CGTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 22,710,700
- Market Cap $9.54M
- Description
- Cognition Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of small molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system and retina. Its lead product candidate is CT1812, a sigma-2 receptor antagonist, which is in Phase II clinical tr...